Assembly Biosciences, Inc.
Assembly Biosciences, Inc. (ASMB) Revenue
Annual & quarterly revenue history · segment & region breakdown
ASMB · revenue · updated Jun 8, 2026
Core revenue metrics
Trailing 12 monthsAssembly Biosciences, Inc. trailing twelve-month (TTM) revenue is $0.07B, an increase of 153.52% year-over-year from $0.07B in FY2025.
Revenue trend
2025 – 2008 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2025-12-31 | $0.07B | +$0.04B | +153.52% |
| 2024-12-31 | $0.03B | +$0.02B | +298.16% |
| 2023-12-31 | $0.01B | +$0.01B | — |
| 2022-12-31 | $0.00B | -$0.01B | -100.00% |
| 2021-12-31 | $0.01B | -$0.07B | -92.09% |
| 2020-12-31 | $0.08B | +$0.06B | +395.55% |
| 2019-12-31 | $0.02B | +$0.00B | +7.83% |
| 2018-12-31 | $0.01B | +$0.01B | +64.15% |
| 2017-12-31 | $0.01B | +$0.01B | — |
| 2016-12-31 | $0.00B | +$0.00B | — |
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Assembly Biosciences, Inc. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Assembly Biosciences, Inc. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from Assembly Biosciences, Inc.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
ASMB revenue · 4 questionsASMB's trailing twelve-month (TTM) revenue is $0.07B. That is an increase of 153.52% year-over-year from $0.07B in FY2025.
▸ Source: FMP · Assembly Biosciences, Inc. SEC filings · GAAP · Assembly Biosciences, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026